GLIPIZIDE Side Effects

6715064-X | Abdominal Pain, Blood Glucose Decreased, Communication Disorder, Lethargy, Weight Decreased
on May 06, 2010 Female patient from UNITED STATES , 84 years of age, weighting 138.9 lb, was diagnosed with diabetes mellitus and was treated with Glipizide (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), blood glucose decreased, communication disorder, lethargy, weight decreased. Glipizide dosage: 5mg Daily Po. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), SENNA (View Senna Review and Senna Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

6712114-1 | Altered State Of Consciousness, Hypoglycaemia
Patient was taking Glipizide (View Usage). Patient had the following side effects: altered state of consciousness, hypoglycaemia on Apr 23, 2010 from FRANCE Additional patient health information: Female patient , 93 years of age, was diagnosed with diabetes mellitus and. Glipizide dosage: 5 Mg, 3x/day. During the same period patient was treated with GLUCOR (50 Mg, 3x/day) (View Glucor Review and Glucor Label ), MEDIATOR (150 Mg, 1x/day) (View Mediator Review and Mediator Label ). Patient was hospitalized.

6654556-9 | Blood Glucose Fluctuation, Blood Glucose Increased
Adverse event was reported on Mar 15, 2010 by a Male patient taking Glipizide (View Usage) (Dosage: 10 Mg, 2x/day) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , weighting 189.6 lb, After Glipizide was administered, patient had the following side effects: blood glucose fluctuation, blood glucose increased. During the same period patient was treated with ACTOS (Unk) (View Actos Review and Actos Label ), CARVEDILOL (Unk) (View Carvedilol Review and Carvedilol Label ), TERAZOSIN (Unk) (View Terazosin Review and Terazosin Label ), SITAGLIPTIN (Unk) (View Sitagliptin Review and Sitagliptin Label ), PLAVIX (Unk) (View Plavix Review and Plavix Label ).

6649736-2 | Convulsion, Hypoglycaemia
on Mar 24, 2010 Male patient from UNITED STATES , 79 years of age, was diagnosed with diabetes mellitus and was treated with Glipizide (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, hypoglycaemia. Glipizide dosage: 10 Mg Every Day Po. During the same period patient was treated with INSULIN (40 Units Am Im) (View Insulin Review and Insulin Label ). Patient was hospitalized.


6646018-X | Alanine Aminotransferase Increased, Blood Glucose Increased, Gingival Disorder, Muscle Spasms, Nasopharyngitis, Oedema Peripheral
on Mar 12, 2010 Male patient from UNITED STATES , weighting 230.0 lb, was diagnosed with diabetes mellitus, muscle spasms, oedema and was treated with Glipizide (View Usage). Patient had the following side effects: alanine aminotransferase increased, blood glucose increased, gingival disorder, muscle spasms, nasopharyngitis, oedema peripheral. Glipizide dosage: 10 Mg, 2x/day. During the same period patient was treated with METFORMIN HCL (Unk) (View Metformin Hcl Review and Metformin Hcl Label ), FINASTERIDE (5 Mg, 1x/day) (View Finasteride Review and Finasteride Label ), IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label ), ACTOS (7.5 Mg, 1x/day) (View Actos Review and Actos Label ).

6642729-0 | Blood Glucose Increased
Patient was taking Glipizide (View Usage). After Glipizide was administered, patient had the following side effects: blood glucose increased on Mar 08, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 270.0 lb, was diagnosed with type 2 diabetes mellitus, arteriosclerosis, hypertension, thyroid disorder and. Glipizide dosage: Unk. During the same period patient was treated with LIPITOR (40 Mg, 1x/day) (View Lipitor Review and Lipitor Label ), METFORMIN HCL/PIOGLITAZONE HCL (15/850, Twice Daily) (View Metformin Hcl/pioglitazone Hcl Review and Metformin Hcl/pioglitazone Hcl Label ), LISINOPRIL (20 Mg, 1x/day) (View Lisinopril Review and Lisinopril Label ), SYNTHROID (0.2 Mg, 1x/day) (View Synthroid Review and Synthroid Label ).

6641563-5 | Abdominal Distension, Hyperhidrosis
Adverse event was reported on Mar 17, 2010 by a Female patient taking Glipizide (View Usage) (Dosage: 5 Mg Bid Po) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 70 years of age, weighting 108.9 lb, Patient experienced the following unwanted or unexpected effects: abdominal distension, hyperhidrosis. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DOCUSATE (View Docusate Review and Docusate Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), ESITALOPRAM (View Esitalopram Review and Esitalopram Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ).

6614530-5 | Confusional State, Hypoglycaemia, Sedation
on Mar 04, 2010 Male patient from UNITED STATES , 71 years of age, was treated with Glipizide (View Usage). Patient had the following side effects: confusional state, hypoglycaemia, sedation. Glipizide dosage: . During the same period patient was treated with METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ). Patient was hospitalized.

6608841-7 | Asthenia, Blood Glucose Fluctuation, Blood Glucose Increased
on Feb 22, 2010 Male patient from UNITED STATES , weighting 189.6 lb, was diagnosed with type 2 diabetes mellitus and was treated with Glipizide (View Usage). After Glipizide was administered, patient had the following side effects: asthenia, blood glucose fluctuation, blood glucose increased. Glipizide dosage: 10 Mg, 2x/day. During the same period patient was treated with ACTOS (Unk) (View Actos Review and Actos Label ), CARVEDILOL (Unk) (View Carvedilol Review and Carvedilol Label ), TERAZOSIN (Unk) (View Terazosin Review and Terazosin Label ), SITAGLIPTIN (Unk) (View Sitagliptin Review and Sitagliptin Label ), PLAVIX (Unk) (View Plavix Review and Plavix Label ).

6595873-0 | Asthenia, Dizziness, Eye Haemorrhage, Eye Pain, Rash Pruritic, Vision Blurred
Patient was taking Glipizide (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, dizziness (What is dizziness?), eye haemorrhage, eye pain, rash pruritic, vision blurred on Feb 19, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 115.0 lb, . Glipizide dosage: Take One Every Day.

6589753-4 | Anaphylactic Reaction, Respiratory Failure
Adverse event was reported on Feb 15, 2010 by a Female patient taking Glipizide (View Usage) (Dosage: ) . Location: UNITED STATES , 65 years of age, Patient had the following side effects: anaphylactic reaction, respiratory failure. Patient was hospitalized.

6584641-1 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased
on Feb 12, 2010 Male patient from UNITED STATES , 75 years of age, weighting 179.9 lb, was diagnosed with diabetes mellitus and was treated with Glipizide (View Usage). After Glipizide was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased. Glipizide dosage: 5 Mg Bid Po.

6583919-5 | Dysgeusia, Paraesthesia Oral
on Feb 13, 2010 Male patient from UNITED STATES , 82 years of age, weighting 177.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Glipizide (View Usage). Patient experienced the following unwanted or unexpected effects: dysgeusia, paraesthesia oral. Glipizide dosage: 5 Mg Daily Po. During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), FINASTERIDE (View Finasteride Review and Finasteride Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), COZAAR (View Cozaar Review and Cozaar Label ), LANTUS (View Lantus Review and Lantus Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6583565-3 | Hypoglycaemia, Mental Status Changes, Syncope
Patient was taking Glipizide (View Usage). Patient had the following side effects: hypoglycaemia, mental status changes, syncope on Feb 12, 2010 from UNITED STATES Additional patient health information: Male patient , 85 years of age, weighting 171.5 lb, was diagnosed with type 2 diabetes mellitus and. Glipizide dosage: 2.5 Mg Every Day Po. Patient was hospitalized.

6571416-2 | Vision Blurred, Visual Impairment
Adverse event was reported on Jan 28, 2010 by a Male patient taking Glipizide (View Usage) (Dosage: 2.5 Mg, 2x/day) was diagnosed with hyperglycaemia, blood glucose increased and. Location: UNITED STATES , weighting 250.0 lb, After Glipizide was administered, patient had the following side effects: vision blurred, visual impairment. During the same period patient was treated with METFORMIN (View Metformin Review and Metformin Label ).

6569281-2 | Abdominal Pain Upper, Asthenia, Hyperhidrosis
on Feb 01, 2010 Male patient from UNITED STATES , 62 years of age, was treated with Glipizide (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, asthenia, hyperhidrosis. Glipizide dosage: .

6567117-7 | Asthenia, Blood Glucose Fluctuation, Blood Glucose Increased, Dialysis
on Jan 25, 2010 Male patient from UNITED STATES , weighting 189.6 lb, was diagnosed with type 2 diabetes mellitus and was treated with Glipizide (View Usage). Patient had the following side effects: asthenia, blood glucose fluctuation, blood glucose increased, dialysis (What is dialysis?). Glipizide dosage: 10 Mg, 2x/day. During the same period patient was treated with ACTOS (Unk) (View Actos Review and Actos Label ), CARVEDILOL (Unk) (View Carvedilol Review and Carvedilol Label ), TERAZOSIN (Unk) (View Terazosin Review and Terazosin Label ), SITAGLIPTIN (Unk) (View Sitagliptin Review and Sitagliptin Label ), PLAVIX (Unk) (View Plavix Review and Plavix Label ).

6555084-1 | Chest Pain, Hypoglycaemia, Respiratory Depression, Syncope, Treatment Noncompliance
Patient was taking Glipizide (View Usage). After Glipizide was administered, patient had the following side effects: chest pain (What is chest pain?), hypoglycaemia, respiratory depression, syncope, treatment noncompliance on Jan 26, 2010 from UNITED STATES Additional patient health information: Male patient , 60 years of age, weighting 199.0 lb, was diagnosed with diabetes mellitus and. Glipizide dosage: 5 Mg Bid Po. During the same period patient was treated with METFORMIN HCL (500 Mg Bid Po) (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

6550855-X | Hypophagia, Mental Status Changes
Adverse event was reported on Jan 22, 2010 by a Male patient taking Glipizide (View Usage) (Dosage: 2.5 Mg Every Day Po) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 82 years of age, weighting 194.7 lb, Patient experienced the following unwanted or unexpected effects: hypophagia, mental status changes. Patient was hospitalized.

6550398-3 | Chills, Discomfort
on Jan 19, 2010 Female patient from SINGAPORE , 66 years of age, was treated with Glipizide (View Usage). Patient had the following side effects: chills, discomfort. Glipizide dosage: .

6522199-3 | Vision Blurred
on Dec 18, 2009 Female patient from SINGAPORE , 61 years of age, was treated with Glipizide (View Usage). After Glipizide was administered, patient had the following side effects: vision blurred. Glipizide dosage: . During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ).

6519426-5 | Dizziness, Hypoglycaemia, Mental Status Changes
Patient was taking Glipizide (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), hypoglycaemia, mental status changes on Dec 24, 2009 from UNITED STATES Additional patient health information: Male patient , 91 years of age, weighting 112.2 lb, was diagnosed with type 2 diabetes mellitus and. Glipizide dosage: 2.5 Mg Every Day Po. Patient was hospitalized.

6507744-6 | Hypoaesthesia, Lip Swelling, Muscular Weakness
Adverse event was reported on Dec 11, 2009 by a Female patient taking Glipizide (View Usage) (Dosage: ) . Location: SINGAPORE , 64 years of age, Patient had the following side effects: hypoaesthesia, lip swelling, muscular weakness.

6507742-2 | Asthenia, Dizziness
on Dec 11, 2009 Female patient from SINGAPORE , 84 years of age, was treated with Glipizide (View Usage). After Glipizide was administered, patient had the following side effects: asthenia, dizziness (What is dizziness?). Glipizide dosage: .

6504273-0 | Hypoglycaemia, Hypophagia
on Dec 08, 2009 Male patient from UNITED STATES , weighting 164.5 lb, was diagnosed with renal transplant and was treated with Glipizide (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia, hypophagia. Glipizide dosage: Unk. During the same period patient was treated with RAD 001 (Unk) (View Rad 001 Review and Rad 001 Label ), NEORAL (Unk) (View Neoral Review and Neoral Label ), PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6503597-0 | Diabetes Mellitus Inadequate Control, Diarrhoea
Patient was taking Glipizide (View Usage). Patient had the following side effects: diabetes mellitus inadequate control, diarrhoea on Dec 07, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 96.00 lb, was diagnosed with type 2 diabetes mellitus and. Glipizide dosage: 2.5 Mg, 1x/day.

6453904-2 | Leukocytoclastic Vasculitis, Rash Pruritic
Adverse event was reported on Nov 11, 2009 by a Female patient taking Glipizide (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: UNITED STATES , 66 years of age, After Glipizide was administered, patient had the following side effects: leukocytoclastic vasculitis, rash pruritic.

6434778-2 | Hypoglycaemia
on Oct 29, 2009 Female patient from SINGAPORE , 57 years of age, was treated with Glipizide (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia. Glipizide dosage: .

6425307-8 | Hypoglycaemia, Mental Status Changes
on Nov 02, 2009 Male patient from UNITED STATES , 77 years of age, weighting 221.8 lb, was diagnosed with diabetes mellitus and was treated with Glipizide (View Usage). Patient had the following side effects: hypoglycaemia, mental status changes. Glipizide dosage: 10 Mg Bid Po. During the same period patient was treated with SULFAMETHOXAZOLE AND TRIMETHOPRIM (1 Tab Bid Po) (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ). Patient was hospitalized.

6423888-1 | Hypoglycaemia
Patient was taking Glipizide (View Usage). After Glipizide was administered, patient had the following side effects: hypoglycaemia on Oct 30, 2009 from UNITED STATES Additional patient health information: Male patient , 80 years of age, weighting 105.2 lb, was diagnosed with diabetes mellitus and. Glipizide dosage: 2.5 Mg Bid Po. Patient was hospitalized.

6422025-7 | Hypoglycaemia, Unresponsive To Stimuli
Adverse event was reported on Oct 29, 2009 by a Male patient taking Glipizide (View Usage) (Dosage: 10 Mg Bid Po) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 74 years of age, weighting 343.9 lb, Patient experienced the following unwanted or unexpected effects: hypoglycaemia, unresponsive to stimuli. During the same period patient was treated with METFORMIN HCL (500 Mg Bid Po) (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

6402213-6 | Blood Glucose Increased
on Oct 14, 2009 Female patient from UNITED STATES , 58 years of age, weighting 168.0 lb, was diagnosed with diabetes mellitus and was treated with Glipizide (View Usage). Patient had the following side effects: blood glucose increased. Glipizide dosage: 10mg. 2x1.

6377362-1 | Alcohol Use, Blood Glucose Decreased, Blood Glucose Increased, Delirium, Depressed Level Of Consciousness, Hypophagia, Metabolic Acidosis, Renal Failure Acute, Treatment Noncompliance
on Sep 23, 2009 Female patient from UNITED STATES , 55 years of age, weighting 201.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with Glipizide (View Usage). After Glipizide was administered, patient had the following side effects: alcohol use, blood glucose decreased, blood glucose increased, delirium, depressed level of consciousness, hypophagia, metabolic acidosis, renal failure acute, treatment noncompliance. Glipizide dosage: 5mg Po Qd Home. During the same period patient was treated with ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), LASIX (View Lasix Review and Lasix Label ), PAXIL (View Paxil Review and Paxil Label ). Patient was hospitalized.

6376920-8 | Diabetes Mellitus Inadequate Control, Stress
Patient was taking Glipizide (View Usage). Patient experienced the following unwanted or unexpected effects: diabetes mellitus inadequate control, stress (What is stress?) on Sep 14, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 110.0 lb, was diagnosed with type 2 diabetes mellitus and. Glipizide dosage: 10 Mg, 2x/day. During the same period patient was treated with TRASTUZUMAB (Unk) (View Trastuzumab Review and Trastuzumab Label ), LIPITOR (Unk) (View Lipitor Review and Lipitor Label ), ANASTROZOLE (Unk) (View Anastrozole Review and Anastrozole Label ), LUMIGAN (Unk) (View Lumigan Review and Lumigan Label ).

6336958-3 | Cardiac Failure
Adverse event was reported on Aug 25, 2009 by a Male patient taking Glipizide (View Usage) (Dosage: Unk) was diagnosed with diabetes mellitus, ischaemic heart disease prophylaxis, stent placement and. Location: UNITED STATES , weighting 104.9 lb, Patient had the following side effects: cardiac failure. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), PLAVIX (View Plavix Review and Plavix Label ).

6329219-X | Diabetes Mellitus Inadequate Control, Stress
on Aug 13, 2009 Female patient from UNITED STATES , weighting 110.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Glipizide (View Usage). After Glipizide was administered, patient had the following side effects: diabetes mellitus inadequate control, stress (What is stress?). Glipizide dosage: 10 Mg, 2x/day. During the same period patient was treated with TRASTUZUMAB (Unk) (View Trastuzumab Review and Trastuzumab Label ), LIPITOR (Unk) (View Lipitor Review and Lipitor Label ), ANASTROZOLE (Unk) (View Anastrozole Review and Anastrozole Label ), LUMIGAN (Unk) (View Lumigan Review and Lumigan Label ).

6312531-8 | Blood Glucose Increased, Cerebral Artery Embolism
on Aug 07, 2009 Female patient from CHINA , 73 years of age, was diagnosed with blood glucose, diabetes mellitus and was treated with Glipizide (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, cerebral artery embolism. Glipizide dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

6312526-4 | Abdominal Distension, Alopecia, Blood Creatine Increased, Blood Glucose Increased, Burning Sensation, Diabetic Neuropathy, Full Blood Count Abnormal
Patient was taking Glipizide (View Usage). Patient had the following side effects: abdominal distension, alopecia, blood creatine increased, blood glucose increased, burning sensation, diabetic neuropathy, full blood count abnormal on Feb 09, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 137.8 lb, . Glipizide dosage: 2.5 Mg, 1x/day. During the same period patient was treated with GLUCOTROL (View Glucotrol Review and Glucotrol Label ), METFORMIN (View Metformin Review and Metformin Label ), LANTUS (8 Units, Unk) (View Lantus Review and Lantus Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), COZAAR (View Cozaar Review and Cozaar Label ).

6306869-8 | Myalgia
Adverse event was reported on Aug 11, 2009 by a Male patient taking Glipizide (View Usage) (Dosage: 2.5mg Daily Po) was diagnosed with diabetes mellitus and. Location: UNITED STATES , 55 years of age, weighting 189.4 lb, After Glipizide was administered, patient had the following side effects: myalgia.

6303892-4 | Leukocytoclastic Vasculitis
on Jul 24, 2009 Female patient from UNITED STATES , 66 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Glipizide (View Usage). Patient experienced the following unwanted or unexpected effects: leukocytoclastic vasculitis. Glipizide dosage: . Patient was hospitalized.

6292597-4 | Benign Renal Neoplasm, Oncocytoma
on Jul 20, 2009 Male patient from UNITED STATES , 80 years of age, weighting 185.0 lb, was diagnosed with diabetes mellitus and was treated with Glipizide (View Usage). Patient had the following side effects: benign renal neoplasm, oncocytoma. Glipizide dosage: . During the same period patient was treated with ACTOS (View Actos Review and Actos Label ).

6289604-1 | Fatigue, Hypoglycaemia, Loss Of Consciousness
Patient was taking Glipizide (View Usage). After Glipizide was administered, patient had the following side effects: fatigue, hypoglycaemia, loss of consciousness on Jul 28, 2009 from UNITED STATES Additional patient health information: Male patient , 79 years of age, was diagnosed with diabetes mellitus and. Glipizide dosage: 2.5mg Daily Po. Patient was hospitalized.

6288260-6 | Epigastric Discomfort, Vomiting
Adverse event was reported on Jul 17, 2009 by a Female patient taking Glipizide (View Usage) (Dosage: ) . Location: SINGAPORE , 59 years of age, Patient experienced the following unwanted or unexpected effects: epigastric discomfort, vomiting.

6283242-2 | Leukocytoclastic Vasculitis
on Jul 11, 2009 Female patient from UNITED STATES , 66 years of age, was diagnosed with diabetes mellitus and was treated with Glipizide (View Usage). Patient had the following side effects: leukocytoclastic vasculitis. Glipizide dosage: .

6277535-2 | Blood Glucose Increased, Cardiac Disorder, Dyspnoea
on Jul 15, 2009 Female patient from UNITED STATES , 71 years of age, was treated with Glipizide (View Usage). After Glipizide was administered, patient had the following side effects: blood glucose increased, cardiac disorder, dyspnoea. Glipizide dosage: Unk. During the same period patient was treated with ACTOS (Unk) (View Actos Review and Actos Label ).

6275957-7 | Hypoglycaemia
Patient was taking Glipizide (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia on Jul 08, 2009 from UNITED STATES Additional patient health information: Male patient , 58 years of age, was diagnosed with type 2 diabetes mellitus, pneumonia (What is pneumonia?) and. Glipizide dosage: 10 Mg; 10 Mg;bid;po. During the same period patient was treated with LEVOFLOXACIN (750 Mg; Po) (View Levofloxacin Review and Levofloxacin Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), REGULAR INSULIN (View Regular Insulin Review and Regular Insulin Label ). Patient was hospitalized.

6274396-2 | Leukocytoclastic Vasculitis
Adverse event was reported on Jul 07, 2009 by a Female patient taking Glipizide (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 66 years of age, Patient had the following side effects: leukocytoclastic vasculitis. Patient was hospitalized.

6268766-6 | Hypoglycaemia
on Jul 13, 2009 Male patient from UNITED STATES , 65 years of age, weighting 119.3 lb, was diagnosed with diabetes mellitus and was treated with Glipizide (View Usage). After Glipizide was administered, patient had the following side effects: hypoglycaemia. Glipizide dosage: 15 Mg Every Day Po. During the same period patient was treated with PIOGLITAZONE (15 Mg Every Day Po) (View Pioglitazone Review and Pioglitazone Label ). Patient was hospitalized.

6267937-2 | Leukocytoclastic Vasculitis
on Jul 02, 2009 Female patient from UNITED STATES , 66 years of age, was diagnosed with diabetes mellitus and was treated with Glipizide (View Usage). Patient experienced the following unwanted or unexpected effects: leukocytoclastic vasculitis. Glipizide dosage: . Patient was hospitalized.

6267294-1 | Hypoglycaemia
Patient was taking Glipizide (View Usage). Patient had the following side effects: hypoglycaemia on Jul 01, 2009 from UNITED STATES Additional patient health information: Male patient , child 5 years of age, weighting 44.09 lb, . Glipizide dosage: 7.5 Mg, 2x/day.